Citadel Advisors
MIST icon

Citadel Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

Citadel Advisors’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Sell
196,696
-156,536
-44% -$274K ﹤0.01% 11067
2025
Q4 		$714K Sell
353,232
-158,835
-31% -$342K ﹤0.01% 8168
2025
Q3 		$1.02M Buy
+512,067
New +$900K ﹤0.01% 7497
2025
Q1 		– Sell
-608,202
Closed -$1.21M – 15167
2024
Q4 		$1.44M Sell
608,202
-1,453,320
-70% -$2.49M ﹤0.01% 6319
2024
Q3 		$3.13M Sell
2,061,522
-85,822
-4% -$125K ﹤0.01% 4700
2024
Q2 		$2.86M Sell
2,147,344
-125,060
-6% -$201K ﹤0.01% 4661
2024
Q1 		$4.07M Buy
2,272,404
+2,037,499
+867% +$3.31M ﹤0.01% 4268
2023
Q4 		$392K Sell
234,905
-61,402
-21% -$167K ﹤0.01% 8607
2023
Q3 		$919K Sell
296,307
-173,443
-37% -$539K ﹤0.01% 6746
2023
Q2 		$1.34M Sell
469,750
-339,743
-42% -$1.28M ﹤0.01% 5883
2023
Q1 		$3.19M Buy
809,493
+9,483
+1% +$34.7K ﹤0.01% 4536
2022
Q4 		$3.17M Buy
800,010
+203,032
+34% +$1.07M ﹤0.01% 4667
2022
Q3 		$5.49M Buy
+596,978
New +$4.53M ﹤0.01% 3720
2021
Q4 		– Sell
-10,466
Closed -$60K – 14388
2021
Q3 		$60K Buy
+10,466
New +$59K ﹤0.01% 13264

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Citadel Advisors's MIST Position: Q1 2026 in Review

Citadel Advisors reduced its Milestone Pharmaceuticals (MIST) stake by 44% in Q1 2026, selling an estimated $274K and leaving 196,696 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #11067.

Citadel Advisors first reported a position in MIST in Q3 2021 and has held it in 14 quarters since. The position peaked at $5.49M in Q3 2022. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Citadel Advisors held 196,696 shares of Milestone Pharmaceuticals worth $234K as of Q1 2026.
  • Citadel Advisors sold 156,536 Milestone Pharmaceuticals shares in Q1 2026, an estimated $274K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11067 holding.
  • Citadel Advisors first reported a position in Milestone Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Milestone Pharmaceuticals position peaked at $5.49M in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.